Abstract:Machine learning methods offer time- and cost-effective means for identifying novel chemical matter as well as guiding experimental efforts to map enormous compound-kinase interaction spaces. However, considerable challenges for compound-kinase interaction modeling arise from the heterogeneity of available bioactivity readouts, including single-dose compound profiling results, such as percentage inhibition, and multi-dose-response results, such as IC . Standard activity prediction approaches utilize only dose-response data in the model training, disregarding a substantial portion of available information contained in single-dose measurements. Here, we propose a novel machine learning methodology for compound-kinase activity prediction that leverages both single-dose and dose-response data. Our two-stage model first learns a mapping between single-dose and dose-response bioactivity readouts, and then generates proxy dose-response activity labels for compounds that have only been tested in single-dose assays. The predictions from the first-stage model are then integrated with experimentally measured dose-response activities to model compound-kinase binding based on chemical structures and kinase features. We demonstrate that our two-stage approach yields accurate activity predictions and significantly improves model performance compared to training solely on dose-response labels, particularly in the most practical and challenging scenarios of predicting activities for new compounds and new compound scaffolds. This superior performance is consistent across five evaluated machine learning methods, including traditional models such as random forest and kernel learning, as well as deep learning-based approaches. Using the best performing model, we carried out extensive experimental profiling on a total of 347 selected compound-kinase pairs, achieving a high hit rate of 40% and a negative predictive value of 78%. We show that these rates can be improved further by incorporating model uncertainty estimates into the compound selection process. By integrating multiple activity data types, we demonstrate that our approach holds promise for facilitating the development of training activity datasets in a more efficient and cost-effective way.

A Hybrid Structure-Based Machine Learning Approach for Predicting Kinase Inhibition by Small Molecules

Leveraging multiple data types for improved compound-kinase bioactivity prediction

Docking-informed machine learning for kinome wide affinity prediction

MinKLIFSAI: a simple machine learning approach toward selective kinase inhibitor

Leveraging Machine Learning and AlphaFold2 Steering to Discover State-Specific Inhibitors Across the Kinome

Integrating Molecular Dynamics and Machine Learning Algorithms to Predict the Functional Profile of Kinase Ligands

Lessons learned during the journey of data: from experiment to model for predicting kinase affinity, selectivity, polypharmacology, and resistance

The Development and Application of KinomePro-DL: A Deep Learning Based Online Small Molecule Kinome Selectivity Profiling Prediction Platform

Using the Structural Kinome to Systematize Kinase Drug Discovery

Meta-learning-based Inductive logistic matrix completion for prediction of kinase inhibitors

Establishment of extensive artificial intelligence models for kinase inhibitor prediction: Identification of novel PDGFRB inhibitors

Kinome-Wide Virtual Screening by Multi-Task Deep Learning

Large-scale comparison of machine learning methods for profiling prediction of kinase inhibitors

Active site sequence representation of human kinases outperforms full sequence for affinity prediction and inhibitor generation: 3D effects in a 1D model

Prediction of Small Molecule Kinase Inhibitors for Chemotherapy Using Deep Learning

Approach for the Design of Covalent Protein Kinase Inhibitors via Focused Deep Generative Modeling

Calibrated geometric deep learning improves kinase–drug binding predictions

Ovine cobalt deficiency in the Coromandel county.

Multimodal multi-task deep neural network framework for kinase–target prediction

Construction of an altered proton donation mechanism in Escherichia coli dihydrofolate reductase.

Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure